Information for clinicians on therapeutic options for COVID-19 patients

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-ncov/index.html

Information for clinicians on therapeutic options for COVID-19 patients

March 21, 2020
By National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
Series: Coronavirus Disease 2019 (COVID-19)

[PDF-65.84 KB]

English

Details Supporting Files Related Documents You May Also Like

Details:

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
Description:

There are no US Food and Drug Administration (FDA)-approved drugs specifically for the treatment of patients with COVID-19. At present clinical management includes infection prevention and control measures and supportive care, including supplementary oxygen and mechanical ventilatory support when indicated. An array of drugs approved for other indications as well as several investigational drugs are being studied in several hundred clinical trials that are underway across the globe. The purpose of this document is to provide information on two of the approved drugs (chloroquine and hydroxychloroquine) and one of the investigational agents (remdesivir) currently in use in the United States.
Subjects:

[+]

Coronavirus Infections/drug Therapy COVID-19/drug Therapy
Series:

Coronavirus Disease 2019 (COVID-19)
Document Type:

Webpage
Collection(s):

Stephen B. Thacker CDC Library collection
Main Document Checksum:

[+]

urn:sha256:8ae63509a2ea673d2f0b6abd40b15825edab25744e5127c0a3689b5fc9d2a314
Download URL:

https://stacks.cdc.gov/view/cdc/86067/cdc_86067_DS1.pdf
File Type:

therapeutic-options.html

htm

More +